Characteristics | Fulminant (n = 9) | Non-fulminant (n = 30) |
---|---|---|
Age | ||
⩽40 y | 44 | 63 |
>40 y | 56 | 37 |
Sex | ||
Male | 89 | 73 |
Female | 11 | 27 |
HCV genotypes | ||
1b | 78 | 83 |
1b+2a/2c or 1b+2b | 22 | 10 |
Not classified | 0 | 7 |
Serum titres of HCV RNA | ||
<105 copies/ml | 78 | 73 |
105–107 copies/ml | 22 | 27 |
Concurrent HGV infection | 11 | 10 |
Concurrent HDV infection | 22 | 7 |
Serum levels of HBV DNA | ||
Undetectable | 44 | 50 |
10–100 pg/ml | 11 | 10 |
101–1000 pg/ml | 11 | 17 |
>1000 pg/ml | 33 | 23 |
Results are expressed as percentages.
p>0.2 by the χ2 test with Yates’ correction for all comparisons between patients with a fulminant course and those with a non-fulminant course.
HBsAg, hepatitis B surface antigen; HCV, hepatitis C virus; HGV, hepatitis G virus; HDV, hepatitis D virus.